new post
StocksRunner logo
mail
search
 
menu
 
Novartis AG
$164.86
+0.39%
 
  Set Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 

NVS Stock Analysis & IQ Rating | Novartis AG

 
 

NVS

 

Novartis AG

$164.86

 
+$0.64 | +0.39%
 
Set Alerts
 
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 
 
52W High
$170.46
 
 
MKT CAP
$344.21B
 
52W Low
$97.72
 
 
VOL
$1.02M
 
P/E Ratio
N/A
 
 
AVG VOL
$2.61M
 
RSI
62.67
 
 
TREND
Uptrend
 
 
 

NVS Stock IQ

 
lock  Login to see Novartis AG (NVS) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

NVS Target Price

 
 
 

Strengths

 
 

NVS Rewards

 Earnings are forecast to grow

NVS Rewards

 Upgraded on attractively valued

NVS Rewards

 Trading below its fair value

 

Risk Analysis

 

NVS Risk Analysis

 Investors losing their confidence

 
 

NVS Price Performance

 
 

$153.95   (+7.09%)

$130.17   (+26.65%)

$131.06   (+25.79%)

$113.21   (+45.62%)

 
 
1year
6month
3month
1month

NVS Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

Earnings

×

Earnings

NVS Earnings Sentiment Reported a weak earnings
NVS Earnings Sentiment Above analyst estimates
NVS Earnings Sentiment Earnings decline YoY

Rating

×

Rating

NVS Rating Sentiment Upgraded on attractively valued

Momentum

×

Momentum

Activity

×

Activity

NVS Activity Sentiment Investors losing their confidence

Future

×

Future

NVS Future Sentiment Earnings are forecast to grow
NVS Future Sentiment Trading below its fair value
NVS Analysts Opinion

NVS Analysts opinion is negative and it remained unchanged from the past 3 months

NVS Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

76%
Consensus Rating
75%
Buy
Opinion
100%
Trend
Score
100%
Potential
Score
NVS Street Sentiment

NVS Street Sentiment is extremely bullish and have positive views on the near-term outlook

NVS Risk Level

NVS has Low risk level

NVS Risk Level
Low
LOW
HIGH

NVS Performance Sentiment

Sentiments overview associated with events and the stock performance

76%
Positive
29 out of 38
events present
21%
Negative
8 out of 38
events present
Very Bullish
Bullish
Neutral
Bearish
Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price
$148.35
Resistance Price
$168.62
Current Price Range
$164.86
$148.35
$168.62
Show methods +
 
 

Analyst Consensus

 

Recent Upgrades and Downgrades

 
 
67%
Consensus Rating
BUY
2
Buy
1
Hold
0
Sell
Date
Action
Rating
Firm

Dec 16, 2025

 

Reiterate

 

Neutral

 

Guggenheim

 

Dec 10, 2025

 

Upgrade

 

Overweight

 

JP Morgan

 

Dec 09, 2025

 

Upgrade

 

Overweight

 

JP Morgan

 

Nov 20, 2025

 

Upgrade

 

Buy

 

Morgan Stanley

 
 
 
NVS Latest Analysis +
 
 
FAQ About NVS Stock Insights
 

What is NVS current stock price?

What are NVS stock strengths?

What is NVS Risk Level?

What is NVS market cap and volume?

What is NVS current Stock IQ?

Should I buy NVS stock right now?

Is NVS a Strong Buy right now?

What does a 'Strong Buy' rating mean for NVS?

What does a 'Strong Sell' rating mean for NVS?

What factors influence NVS's Stock IQ?

 
 
StocksRunner

Explore our NVS Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored NVS Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our NVS Daily Alerts

Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
 
 

NVS

 

Novartis AG

 
Set Alerts
 
 

Current Price

 

$164.86

 
+$0.64 | +0.39%
 
 
52W High
$170.46
 
 
MKT CAP
$344.21B
 
52W Low
$97.72
 
 
VOL
$1.02M
 
P/E Ratio
N/A
 
 
AVG VOL
$2.61M
 
RSI
62.67
 
 
TREND
Uptrend
 
 
 
  Overview  
  
  Comments  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
 
 
 
 
user
 
 
 
 

NVS Price Performance

 
 

$153.95   (+7.09%)

$130.17   (+26.65%)

$131.06   (+25.79%)

$113.21   (+45.62%)

 
 
1year
6month
3month
1month
 

NVS Analysts Opinion

Overall standing per market and analyst expectations. menu Hover over the category for more information

Earnings

×

Earnings

NVS Earnings Sentiment Reported a weak earnings
NVS Earnings Sentiment Above analyst estimates
NVS Earnings Sentiment Earnings decline YoY

Rating

×

Rating

NVS Rating Sentiment Upgraded on attractively valued

Momentum

×

Momentum

Activity

×

Activity

NVS Activity Sentiment Investors losing their confidence

Future

×

Future

NVS Future Sentiment Earnings are forecast to grow
NVS Future Sentiment Trading below its fair value
NVS Analysts Opinion

NVS Analysts opinion is negative and it remained unchanged from the past 3 months

NVS Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

76%
Consensus Rating
75%
Buy
Opinion
100%
Trend
Score
100%
Potential
Score
NVS Street Sentiment

NVS Street Sentiment is extremely bullish and have positive views on the near-term outlook

NVS Risk Level

NVS has Low risk level

NVS Risk Level
Low
LOW
HIGH
NVS Performance Sentiment
Sentiments overview associated with events and the stock performance.
76%
Positive
29 out of 38
events present
21%
Negative
8 out of 38
events present
Very Bullish
Bullish
Neutral
Bearish
Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price
$148.35
Resistance Price
$168.62
Current Price Range
$164.86
$148.35
$168.62
Show methods +

Latest Analyst Actions

Overall Wall Street Rating

67%
Consensus Rating
BUY
2
Buy
1
Hold
0
Sell
Date
Action
Rating
Firm
Dec 16, 2025
Reiterate
Neutral
Guggenheim
Dec 10, 2025
Upgrade
Overweight
JP Morgan
Dec 09, 2025
Upgrade
Overweight
JP Morgan
Nov 20, 2025
Upgrade
Buy
Morgan Stanley
 
 
 
 

NVS Stock IQ

 
 
 
lock  Login to unlock Novartis AG (NVS) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 
 

Target Price

 
 
 
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 
 

NVS Rewards

 Earnings are forecast to grow

NVS Rewards

 Upgraded on attractively valued

NVS Rewards

 Trading below its fair value

 

Risk Analysis

 
 

NVS Risk Analysis

 Investors losing their confidence

 
 
 

NVS Latest Analysis

 
 
 

Whats Driving the Market Sentiment Around Novartis AG?. Novartis AG'.s (NYSE:NVS) short interest as a percent of float has risen 44.44% since its last report. According to exchange reported data there are now 7.49 million shares sold short which is 0.39% of all regular shares that are available for trading. Based on its trading volume it would take traders 2.47 days to cover their short positions on average.Why Short Interest MattersShort interest is the number of shares that have been sold

 

Mon Mar 2, 2026

$166.87 | -1.04%
 
Activity

Avidity (RNA) Moves Date for Shareholder Vote on Novartis Merger. Avidity Biosciences Inc. (NASDAQ:RNA) is one of 15 stocks with the biggest hedge fund momentum after gaining 28 hedge fund holders during the fourth quarter of 2025. On February 23 Avidity Biosciences Inc. (NASDAQ:RNA) adjourned its special stockholder meeting scheduled for the same day and moved the date to February 26. Avidity Biosciences Inc. (NASDAQ:RNA) [….]

 

Fri Feb 27, 2026

$168.62 | +1.88%
 
Activity

Novartis receives positive CHMP opinion for remibrutinib in chronic spontaneous urticaria (CSU). Basel February 27 2026 – Novartis announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending marketing authorization for remibrutinib. The opinion supports its use as an oral treatment for chronic spontaneous urticaria (CSU) in adult patients with inadequate response to H1‑antihistamine treatment.Th

 

Fri Feb 27, 2026

$168.62 | +1.88%
 
Activity

Novartis picks Texas to build next radioligand therapy site.

 

Wed Feb 25, 2026

$166.85 | -0.17%
 
Activity

Novartis presents Rhapsido® (remibrutinib) data at AAAAI showing potential beyond chronic spontaneous urticaria (CSU). ® (remibrutinib) in chronic spontaneous urticaria (CSU) and as an investigational therapy for peanut allergy at the American Academy of Allergy Asthma &. Immunology (AAAAI) Annual Meeting in Philadelphia PA from February 27 to March 2 2026. These presentations provide more evidence on the use of Rhapsido in CSU as well as its potential in other indications and highlight Novar

 

Mon Feb 23, 2026

$164.70 | +1.25%
 
Activity

Trump says tariffs prompt Novartis to expand United States manufacturing.

 

Fri Feb 20, 2026

$162.67 | -0.76%
 
Activity

Novartis to sell 70.7% stake in Indian unit for $159M.

 

Fri Feb 20, 2026

$162.67 | -0.76%
 
Activity
Activity
 
 
 
 
 
StocksRunner

Discover NVS Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of NVS. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our NVS Daily Alerts

Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

NVS Stock trends

NVS Stock performance

NVS Stock analysis

NVS investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

NVS Alerts

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental Indicator (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 
 
Cancel
 
×
 
0/666
joker
 
Post
 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing NVS

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing NVS

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.